Literature DB >> 28963610

Patients' Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease Carriers.

Maureen Mulhern1, Louise Bier2, Roy N Alcalay3, Manisha Balwani2.   

Abstract

Gaucher disease (GD) is an autosomal recessive disease caused by GBA mutations that is especially common in the Ashkenazi Jewish (AJ) population. The link between GBA mutations and Parkinson disease (PD), a later-onset neurodegenerative condition, is well established, and studies have shown that GBA carriers have an increased lifetime risk of developing PD. Carrier screening for GD is frequently offered to couples during or prior to pregnancy, especially to those of AJ descent. However, no studies have been performed to assess if prospective parents would want to learn about their risk of developing PD incidentally through carrier screening. It is also unknown if pre-test counseling on this topic would affect screening uptake. In order to answer these questions, a survey was administered to individuals who screened negative for GBA mutations. Of the 75 participants, 86.7% believed that patients should be informed about the increased risk of PD prior to having GD carrier screening, and 93.3% responded that this information would not have changed their decision to have carrier screening. These results indicate that healthcare providers should take into consideration patient preferences when determining how to counsel about GD carrier screening. Additionally, these results have implications for genetic counseling about other later-onset conditions that may be incidentally ascertained through carrier screening.

Entities:  

Keywords:  Carrier screening; Gaucher disease; Parkinson disease; Reproductive genetic counseling

Mesh:

Year:  2017        PMID: 28963610      PMCID: PMC5878114          DOI: 10.1007/s10897-017-0161-0

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  14 in total

1.  Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.

Authors:  M Anheim; A Elbaz; S Lesage; A Durr; C Condroyer; F Viallet; P Pollak; B Bonaïti; C Bonaïti-Pellié; A Brice
Journal:  Neurology       Date:  2012-01-25       Impact factor: 9.910

2.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Authors:  E Sidransky; M A Nalls; J O Aasly; J Aharon-Peretz; G Annesi; E R Barbosa; A Bar-Shira; D Berg; J Bras; A Brice; C-M Chen; L N Clark; C Condroyer; E V De Marco; A Dürr; M J Eblan; S Fahn; M J Farrer; H-C Fung; Z Gan-Or; T Gasser; R Gershoni-Baruch; N Giladi; A Griffith; T Gurevich; C Januario; P Kropp; A E Lang; G-J Lee-Chen; S Lesage; K Marder; I F Mata; A Mirelman; J Mitsui; I Mizuta; G Nicoletti; C Oliveira; R Ottman; A Orr-Urtreger; L V Pereira; A Quattrone; E Rogaeva; A Rolfs; H Rosenbaum; R Rozenberg; A Samii; T Samaddar; C Schulte; M Sharma; A Singleton; M Spitz; E-K Tan; N Tayebi; T Toda; A R Troiano; S Tsuji; M Wittstock; T G Wolfsberg; Y-R Wu; C P Zabetian; Y Zhao; S G Ziegler
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

3.  ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-10       Impact factor: 7.661

4.  Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.

Authors:  Roy N Alcalay; Tama Dinur; Timothy Quinn; Karina Sakanaka; Oren Levy; Cheryl Waters; Stanley Fahn; Tsvyatko Dorovski; Wendy K Chung; Michael Pauciulo; William Nichols; Huma Q Rana; Manisha Balwani; Louise Bier; Deborah Elstein; Ari Zimran
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

5.  Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes.

Authors:  Manisha Balwani; Laura Fuerstman; Ruth Kornreich; Lisa Edelmann; Robert J Desnick
Journal:  Arch Intern Med       Date:  2010-09-13

Review 6.  Gaucher disease and its treatment options.

Authors:  Lunawati L Bennett; Devipriya Mohan
Journal:  Ann Pharmacother       Date:  2013-09       Impact factor: 3.154

Review 7.  Gaucher disease: haematological presentations and complications.

Authors:  Alison S Thomas; Atul Mehta; Derralynn A Hughes
Journal:  Br J Haematol       Date:  2014-03-03       Impact factor: 6.998

Review 8.  The prevalence of Parkinson's disease: a systematic review and meta-analysis.

Authors:  Tamara Pringsheim; Nathalie Jette; Alexandra Frolkis; Thomas D L Steeves
Journal:  Mov Disord       Date:  2014-06-28       Impact factor: 10.338

9.  Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling.

Authors:  Huma Q Rana; Manisha Balwani; Louise Bier; Roy N Alcalay
Journal:  Genet Med       Date:  2012-08-30       Impact factor: 8.822

10.  A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers.

Authors:  Alisdair McNeill; Raquel Duran; Derralynn A Hughes; Atul Mehta; Anthony H V Schapira
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-05-10       Impact factor: 10.154

View more
  6 in total

Review 1.  GBA-Associated Parkinson's Disease and Other Synucleinopathies.

Authors:  Ziv Gan-Or; Christopher Liong; Roy N Alcalay
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-08       Impact factor: 5.081

Review 2.  Genetics of Movement Disorders and the Practicing Clinician; Who and What to Test for?

Authors:  Alessio Di Fonzo; Edoardo Monfrini; Roberto Erro
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

3.  A cross-sectional survey of genetic counselors providing carrier screening regarding GBA variants and Parkinson disease susceptibility.

Authors:  Tara A Jones; Jeanine Schulze; Sharon Aufox; Jason Rothstein; Aishwarya Arjunan
Journal:  J Assist Reprod Genet       Date:  2022-02-11       Impact factor: 3.412

4.  Genome Sequencing in the Parkinson Disease Clinic.

Authors:  Emily J Hill; Laurie A Robak; Rami Al-Ouran; Jennifer Deger; Jamie C Fong; Paul Jerrod Vandeventer; Emily Schulman; Sindhu Rao; Hiba Saade; Joseph M Savitt; Rainer von Coelln; Neeja Desai; Harshavardhan Doddapaneni; Sejal Salvi; Shannon Dugan-Perez; Donna M Muzny; Amy L McGuire; Zhandong Liu; Richard A Gibbs; Chad Shaw; Joseph Jankovic; Lisa M Shulman; Joshua M Shulman
Journal:  Neurol Genet       Date:  2022-06-09

5.  Evaluation of the frequency of non-motor symptoms of Parkinson's disease in adult patients with Gaucher disease type 1.

Authors:  Matheus V M B Wilke; Alícia D Dornelles; Artur S Schuh; Filippo P Vairo; Suelen P Basgalupp; Marina Siebert; Tatiele Nalin; Otavio B Piltcher; Ida V D Schwartz
Journal:  Orphanet J Rare Dis       Date:  2019-05-10       Impact factor: 4.123

6.  Parkinson's disease in Gaucher disease patients: what's changing in the counseling and management of patients and their relatives?

Authors:  Maja Di Rocco; Alessio Di Fonzo; Antonio Barbato; Maria Domenica Cappellini; Francesca Carubbi; Fiorina Giona; Gaetano Giuffrida; Silvia Linari; Andrea Pession; Antonella Quarta; Maurizio Scarpa; Marco Spada; Pietro Strisciuglio; Generoso Andria
Journal:  Orphanet J Rare Dis       Date:  2020-09-23       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.